Ticker Symbol: PCRX
Pacira BioSciences Inc
$57.03 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001396814
Company Profile
Pacira BioSciences, Inc.is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients' journeys along the neural pain pathway. The company's long-acting local analgesic, EXPAREL ® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera° system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 5 Sylvan Way Ste 300
Website: www.pacira.com
CEO: David M. Stack
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $29.23
Change:
-$0.63
(
-2.11%)
Days Range: $28.54 - $29.78
Beta: 0.74
52wk. High: $54.78
52wk. Low: $28.31
Ytd. Change -24.77%
50 Day Moving Average: $31.88
200 Day Moving Average: $37.72
Shares Outstanding: 46417025
Valuation
Market Cap: 135.7B
PE Ratio: -296.45
EPS (TTM): -0.0986
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A